Cancer Care and Treatment
Diagnosis and staging of cancer
Diagnosis
In almost all cases, the disease, cancer, is diagnosed by a specialist following a microscopic examination of tissue or cell samples of a particular individual. In a few instances, physicians may know of the presence of a cancer with the aid of tests performed on DNA (deoxyribo-nucleic acid), RNA (ribo-nucleic acid) and cell proteins. Such tests' outcomes prove highly critical when it comes to selecting the optimal therapeutic alternative. Tissue and cell examinations may also aid in the diagnoses of a number of other forms of ailments. For example, if a physician is unsure of whether a particular lump or growth in a patient's body is cancer, he/she might extract a little bit of it for testing to diagnose any one of many problems, including cancer, infections and other issues which may lead to the development of cancer-like lumps. This process of obtaining a bit of an unnatural bodily growth (sample) for the purpose of carrying out tests is termed biopsy, while the tissue/cell sample is labeled as a biopsy specimen. The process has been termed as pathology by some. Potentially cancerous growths may be detected by means of imaging tests or even sensed as lumps in physical patient examinations. However, the confirmation of their true nature (carcinogenic or not) necessitates sampling and microscopic scrutiny. Every abnormal growth isn't cancerous; as a matter of fact, a majority of tumors are non-carcinogenic in nature (The American Cancer Society medical and editorial content team, 2015).
Low or high levels of particular substances within the body may indicate the development of cancer. Hence, physicians may make appropriate diagnoses with the assistance of laboratory examinations of body fluids (urine, blood, etc.). But a key point to note is that unusual laboratory test results do not assuredly mean the individual has developed a cancer. While laboratory examinations do mark a significant tool, physicians mustn't depend solely on them for making cancer diagnoses. In a majority of instances, there is a need to perform biopsies before categorically making a cancer diagnosis. Biopsies, in simple words, denote processes wherein physicians extract a tissue sample and send it to a pathologist who undertakes a microscopic examination of it to ascertain whether or not the growth is a cancer. The following techniques may be utilized to obtain tissue/cell samples:
• Using needles: A needle is employed for withdrawing body fluids or tissues.
• Using endoscopes: Endoscopes are slender lighted tubes utilized by physicians to view areas within a patient's body. The mouth and other natural body openings are the entryways of these scopes. Subsequently, the physician withdraws...
Quite frequently, parts of normal body tissue surrounding the lump are removed as well.
• Incisional biopsies entail the removal of only some part of an abnormal growth.
Staging of Cancer
Cancer staging may be defined as a process whereby healthcare providers ascertain the quantity of cancer in a patient's body and its precise location. This procedure helps ascertain how grave the patient's disease is, depending on both the primary/initial growth size and how far it has extended within the patient's body. Determining disease stage facilitates the development of patient prognoses and treatment plans (AJCC, 2017).
The most extensively utilized system for cancer staging is the TNM staging system, with a majority of healthcare organizations and facilities employing it as their chief cancer diagnosis technique. Most cancers can be defined using this system, with the exception of a few such as blood cancers, spinal cord and brain tumors, which require different systems for staging.
Within the TNM staging system:
• T. implies the main/primary tumor's magnitude and range.
• N. denotes the amount of surrounding cancer-afflicted lymph nodes and • M. implies a determination of whether or not the given cancer has metastasized (i.e., spread into the patient's body from the main tumor site).
Cancers described using this system are accompanied by numbers following individual letters for providing further details regarding the patient's cancer (e.g., T3N1M0 or T1N0MX). The meaning of the numbers and alphabets has been described in the following section:
Primary Tumor (T)
T0: Primary tumor can't be detected.
TX: Primary tumor can't be measured.
T1, T2, T3, and T4: Denotes the primary tumor's magnitude and range; the bigger the number, the greater its size, or extent of growth into surrounding tissues. This can be subdivided further in order to offer additional details (e.g., T3a, T3b, etc.)
Regional Lymph Nodes (N)
N0: Surrounding lymph nodes are free of cancer.
NX: It is not possible to measure the cancer within the surrounding lymph nodes.
N1, N2, and N3: Denotes the location and number of cancer-afflicted lymph nodes; the bigger the number, the larger number of cancer-afflicted lymph nodes.
Distant Metastasis (M)
M0: Other body areas haven't been affected by the cancer.
M1: Other body areas have been affected by the…
Cancer Care KNOWING MORE ABOUT CANCER Approach to the Care of Cancer The integrative approach to cancer treatment is the most widely used by cancer patients today as it is the most comprehensive (Nelson, 2011). It is the method used by integrative oncology, which combines complementary therapeutic approaches and conventional therapies. As a combination, the integrated approach covers natural and botanical products, nutrition, acupuncture, traditional Chinese medicine and mind-body therapies. It fits together
Bmj.com/cgi/content/full/325/7369/887 Pfizer, 'NEW FRAGMIN INDICATION FIGHTS SECOND LEADING CAUSE of DEATH in CANCER PATIENTS, CANCER-ASSOCIATED THROMBOSIS', retrieved feb 29th 2008, from, http://www.pfizer.ca/english/newsroom/press%20releases/default.asp?s=1&releaseID=160 Dirix LY, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P, van Dam P, Prove a, Lemmens J, Vermeulen P. (2002), 'Plasma fibrin D-dimer levels correlate with tumor volume, progression rate and survival in patients with metastatic Breast Cancer', British Journal of Cancer, http://www.ncbi.nlm.nih.gov/pubmed/11875705 John a Heit, (Sep 2005), "Cancer and Venous Thromboembolism: Scope of the Problem', Cancer
skin care treatment from a qualified trained oncology esthetician? The skin of an oncology patient is usually compromised by the intensive oncology treatments administered. This leaves the skin of detoxification from both external toxins and medication residuals on and in the body. Restoration of the skin through gentle detoxifying ingredients and massage techniques is best applied by a board certified esthetician who specializes in oncology esthetic. Normally skin treatments for
This study attests that looking good makes oral cancer patients feel good about themselves. Cosmetic rehabilitation training should be part of oral nursing care. [Huang S, 2008] 2006 study by Millsopp et.al looked at facial disfigurement in oral and oropharyngeal cancer cases post surgery. The researchers specifically studied the type of support that was offered to patients who had reported distress pertaining to their appearance after their surgeries. Of the
Cancer Drug Development Economic issues Special health needs Process (decision, steps) involved in program Benefits of program Cancer is amongst fatal diseases that involve abnormal growth of body cells resulting is unusual growth and division of cells. The result is tumor formation effecting one particular or many parts of the body. Since there is high probability of cancer cells invading the neighboring tissues of body parts, early detection and careful treatment of cancer is deemed
, about 700,000 deaths per annum); Bone (Leukemia) (cancer of the blood or bone marrow and characterized by an abnormal proliferation of white blood cells); Lymphoma (Lymphatic) (cancer that begins in the lymphocytes of the immune system then presents as a solid tumor, many types, many treatments); Brain (Neuro/Nervous) (abnormal growth of cells within the brain, can be cancerous or non-cancerous, 50,000 U.S. cases per annum, 13,000 deaths per annum);